SHANGHAI, China, Jan. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's leading provider of pharmaceutical R&D outsourcing services is proud to announce today that its Chairman and Chief Executive Officer Dr. Ge Li is named as one of the 2007 China Top 10 Influential Entrepreneurs selected by Entrepreneur China edition.
The 2007 China Top 10 Influential Entrepreneurs selection, organized by Entrepreneur China edition, aims to honor Chinese entrepreneurs who have enabled enormous leaps for their enterprises and whose experiences have prompted profound changes in the Chinese society during the year of 2007. The selection of the winners is based on a comprehensive set of parameters to evaluate the entrepreneur's contribution to revenue growth, employment opportunities, industry impact, public influence and social recognition, capital market performance, wealth creation for employees, as well as social responsibilities. Seeking to exemplify China's most successful entrepreneurs and inspire the new generation to run their own businesses, the organizer selected China's ten most influential business luminaries from over 100 achieved entrepreneurs who brought their companies public in 2007.
Dr. Li has won the award because of his deep understanding of the global pharmaceutical R&D outsourcing market and the successful implementation of his visionary business model and strategy in China. "Under Dr. Li's leadership, WuXi PharmaTech is playing an increasingly important role in the global drug discovery and development industry. This eventually will positively impact China's pharmaceutical industry," according to Entrepreneur.
Founded in 2000, through seven years of rapid development, WuXi PharmaTech has gained trust and confidence from the world's leading pharmaceutical and biotechnology companies for its high quality drug R&D outsourcing services. In August 2007, WuXi PharmaTech went public as the first NYSE listed company in China's rapidly growing pharmaceutical R&D outsourcing industry.
"I am very honored to be included on this list and to see WuXi PharmaTech's success recognized by Entrepreneur," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Our modest success is attributable to the support and trust from our customers and our unwavering focus on quality. China's advantageous business environment and rapid economic growth have created many opportunities for entrepreneurs. I hope more people can realize their dreams and create value for their customers, employees and the society."
About Entrepreneur China Edition
Entrepreneur China edition is a monthly business magazine issued by International Data Group (IDG) and Zero2IPO Group. As China's sole licensed partner of Entrepreneur Media Inc., Entrepreneur China edition provides networks and guidelines to Chinese entrepreneurs by offering Chinese business owners with inspiration and information on marketing, management, technology, the latest trends and strategies.
About WuXi PharmaTech
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading
China-based pharmaceutical and biotechnology R&D outsourcing company. As a
research- driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical and biotechnology companies with a broad and integrated
portfolio of laboratory and research manufacturing services throughout the
drug discovery and development process. WuXi PharmaTech's services are
designed to assist its global partners in shortening the cycle and lowering
the cost of drug discovery and development by providing cost-effective and
efficient outsourcing solutions that save its customers both time and
money. Its operations are grouped into two segments: laboratory services,
consisting of discovery chemistry, service biology, analytical, toxicology,
pharmaceutical development and process development services; and research
manufacturing, focusing on manufacturing of advanced intermediates and
active pharmaceutical ingredients for R&D use. In 2007, its 80 customers
included nine of the world's top ten pharmaceutical companies by revenue.
For more information, please visit: http://www.wuxipharmatech.com .
For more information, please contact:
|SOURCE WuXi PharmaTech|
Copyright©2008 PR Newswire.
All rights reserved